GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (OTCPK:FMCQF) » Definitions » Days Sales Outstanding

Fresenius Medical Care AG (Fresenius Medical Care AG) Days Sales Outstanding

: 66.98 (As of Dec. 2023)
View and export this data going back to 2009. Start your Free Trial

Fresenius Medical Care AG's average Accounts Receivable for the three months ended in Dec. 2023 was $3,992 Mil. Fresenius Medical Care AG's Revenue for the three months ended in Dec. 2023 was $5,439 Mil. Hence, Fresenius Medical Care AG's Days Sales Outstanding for the three months ended in Dec. 2023 was 66.98.

The historical rank and industry rank for Fresenius Medical Care AG's Days Sales Outstanding or its related term are showing as below:

FMCQF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.77   Med: 73.72   Max: 81.55
Current: 70.31

During the past 13 years, Fresenius Medical Care AG's highest Days Sales Outstanding was 81.55. The lowest was 67.77. And the median was 73.72.

FMCQF's Days Sales Outstanding is ranked worse than
73.47% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 46.01 vs FMCQF: 70.31

Fresenius Medical Care AG's Days Sales Outstanding declined from Dec. 2022 (67.63) to Dec. 2023 (66.98).


Fresenius Medical Care AG Days Sales Outstanding Historical Data

The historical data trend for Fresenius Medical Care AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.11 65.81 72.47 69.97 68.25

Fresenius Medical Care AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.63 74.20 71.81 68.54 66.98

Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Days Sales Outstanding Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Days Sales Outstanding falls into.



Fresenius Medical Care AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Fresenius Medical Care AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (3913.155 + 4020.736) / 2 ) / 21214.413*365
=3966.9455 / 21214.413*365
=68.25

Fresenius Medical Care AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (3963.961 + 4020.736) / 2 ) / 5439.352*365 / 4
=3992.3485 / 5439.352*365 / 4
=66.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius Medical Care AG  (OTCPK:FMCQF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Fresenius Medical Care AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.